Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Topwin Speedy Enema

Last content change checked dailysee data sync status

Active ingredient
Glycerin 3 g/100 mL
Other brand names
Drug class
Non-Standardized Chemical Allergen
Dosage form
Enema
Route
Rectal
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2020
Label revision date
November 28, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Glycerin 3 g/100 mL
Other brand names
Drug class
Non-Standardized Chemical Allergen
Dosage form
Enema
Route
Rectal
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2020
Label revision date
November 28, 2025
Manufacturer
Health Chemical Pharmaceutical Co. , Ltd
Registration number
M007
NDC root
73513-323
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Topwin Speedy Enema is a medication designed to provide relief from occasional constipation. It works by helping to stimulate bowel movements, making it easier for you to pass stool. If you're experiencing discomfort due to constipation, this product may be a helpful option to consider for easing your symptoms.

Uses

If you're experiencing occasional constipation, this medication can help provide relief. It works by softening your stool, making it easier to pass. Remember, occasional constipation can happen to anyone, and using this medication can help you feel more comfortable and regular again. Always follow the recommended guidelines for use to ensure the best results.

Dosage and Administration

When using this medication, you will typically take it once a day. For adults and children aged 6 years and older, the recommended dose is 20 ml, which contains 3 grams of glycerin. If your child is between 3 and 6 years old, the dose is reduced to 10 ml, or 1.5 grams of glycerin. Always follow your doctor’s instructions regarding the exact dosage.

To use the medication, you should be in a knee-chest or upright position. Before inserting the enema (a liquid treatment delivered into the rectum), it’s important to lubricate the anus with petroleum jelly to make the process smoother. Gently insert the tip of the enema applicator into the rectum, moving it side to side to avoid causing any damage. After insertion, allow 15 minutes to 1 hour for the medication to work and produce a bowel movement. Remember to discard the applicator after use, and do not reuse any leftover fluid.

What to Avoid

You should avoid using this medication if you have rectal irritation, abdominal pain, nausea, fever, or vomiting, unless your doctor specifically instructs you to do so. These conditions can indicate a more serious issue that requires medical attention.

It's important to be aware that this medication may be associated with risks of abuse or misuse, as well as dependence (a condition where your body becomes reliant on a substance). Always follow your healthcare provider's guidance to ensure safe and effective use.

Side Effects

If you experience any discomfort, burning sensation, or rectal bleeding after using this product, it's important to stop using it and consult your doctor. Additionally, if you do not have a bowel movement within one hour of use, you should also seek medical advice.

Before using any laxative, you should talk to your doctor if you have noticed a sudden change in your bowel habits that lasts more than two weeks or if you have been using a laxative for more than one week. Remember, this product is intended for rectal use only.

Warnings and Precautions

This product is intended for rectal use only. It’s important to avoid using it if you have rectal irritation, abdominal pain, nausea, fever, or vomiting unless your doctor has specifically advised you to do so.

You should stop using this product and contact your doctor if you experience any rectal discomfort, a burning sensation, rectal bleeding, or if you do not have a bowel movement within one hour of using it. If the product is swallowed, seek emergency medical help or contact a Poison Control Center immediately.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's always important to be aware of the signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect that you or someone else may have taken too much of a medication, it’s crucial to seek immediate medical help.

In case of an overdose, contact your local emergency services or go to the nearest hospital right away. Having the medication packaging or details on hand can help healthcare professionals provide the best care. Always remember, when in doubt, it’s better to be safe and get help.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that there is no specific information available about the use of glycerin enemas during pregnancy. The insert does not mention any risks or contraindications associated with using this product while pregnant, nor does it provide any dosage modifications for pregnant individuals. Additionally, there are no special precautions outlined for pregnant patients.

While this may suggest that glycerin enemas are generally considered safe, it's always best to consult with your healthcare provider before using any medication or treatment during pregnancy to ensure it is appropriate for your individual situation.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to consult your doctor before using this product. There is a possibility that the ingredients may pass into your breast milk, which could pose risks to your infant. Therefore, exercising caution is essential when considering this medication while nursing. Always prioritize your health and your baby's safety by discussing any concerns with your healthcare provider.

Pediatric Use

When using this medication for children aged 3 to 6 years, the recommended dosage is 10 ml (1.5g of Glycerin), or as directed by your doctor. For children aged 6 years and older, the dosage increases to 20 ml (3g of Glycerin). It's important to follow the administration instructions carefully: have your child in a knee-chest or upright position, lubricate the anus with petroleum jelly, and gently insert the enema applicator tip into the rectum. This should be done with a single side-to-side movement to avoid injury. After administering, allow 15 minutes to 1 hour for a bowel movement to occur, and remember to discard the unit after use—never reuse any leftover fluid.

Always keep this medication out of reach of children. If a child accidentally swallows it, seek medical help or contact a Poison Control Center immediately.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. If you or a loved one is an older adult, it’s wise to discuss any potential risks or benefits with your healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken.

Always keep in mind that older adults may have different responses to medications, so regular check-ins with your doctor can ensure safety and effectiveness. If you notice any unusual side effects or changes in health, be sure to report these to your healthcare team promptly.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver function and how it relates to your treatment. They can help ensure that your medication is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.

Always feel free to ask questions and share your complete list of medications and any tests you might be undergoing. This way, you can avoid any potential issues and receive the best care possible.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, dry place at temperatures below 77°F (25°C) and keep it away from direct sunlight. This helps maintain its effectiveness and integrity.

When handling the product, please check that the cap is intact before use. If the cap is broken, do not use the product, as this could compromise its safety and effectiveness. Always prioritize these storage and handling guidelines to ensure optimal use.

Additional Information

No further information is available.

FAQ

What is Topwin Speedy Enema used for?

Topwin Speedy Enema is used for the relief of occasional constipation.

What is the recommended dosage for adults and children over 6 years?

The recommended dosage for adults and children 6 years and over is 20 ml (3g Glycerin) or as directed by a doctor.

What dosage should children aged 3-6 years take?

Children aged 3-6 years should take 10 ml (1.5g Glycerin) or as directed by a doctor.

How should Topwin Speedy Enema be administered?

It should be administered in a knee-chest or upright position, with lubrication applied to the anus. Gently insert the applicator tip into the rectum and allow 15 minutes to 1 hour for a bowel movement.

What should I do if I experience rectal discomfort or bleeding?

Stop using the product and ask a doctor if you experience rectal discomfort, burning sensation, rectal bleeding, or no bowel movement within 1 hour of use.

Are there any contraindications for using Topwin Speedy Enema?

Do not use it if you have rectal irritation, abdominal pain, nausea, fever, or vomiting unless directed by a doctor.

Is it safe to use Topwin Speedy Enema during pregnancy?

The insert does not provide specific information regarding the use of Topwin Speedy Enema during pregnancy, so consult a doctor before use.

What precautions should nursing mothers take?

Nursing mothers should consult a doctor before using this product due to the potential for excretion in breast milk.

How should Topwin Speedy Enema be stored?

Store it below 77°F (25 °C) in a cool, dry place and protected from sunlight. Do not use if the cap is broken.

What should I do if Topwin Speedy Enema is swallowed?

If swallowed, get medical help or contact a Poison Control Center right away.

Packaging Info

Below are the non-prescription pack sizes of Topwin Speedy Enema (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Topwin Speedy Enema.
Details

Drug Information (PDF)

This file contains official product information for Topwin Speedy Enema, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of occasional constipation. It is intended for use in patients experiencing infrequent bowel movements or difficulty in passing stools.

Dosage and Administration

For adults and children aged 6 years and over, the recommended dosage is 20 ml (3 g of Glycerin) administered once daily, or as directed by a healthcare professional. For children aged 3 to 6 years, the dosage is 10 ml (1.5 g of Glycerin), also administered once daily or as directed by a healthcare professional.

The enema should be administered in a knee-chest or upright position. Prior to administration, the anus should be lubricated with petroleum jelly to facilitate insertion. The tip of the enema applicator should be gently inserted into the rectum using a single side-to-side movement to minimize the risk of damage to the rectal wall.

After administration, it is recommended to allow a period of 15 minutes to 1 hour for the enema to produce a bowel movement. Following use, the enema unit should be discarded, and any remaining fluid should not be reused.

Contraindications

Use is contraindicated in patients experiencing rectal irritation, abdominal pain, nausea, fever, or vomiting, unless directed by a healthcare professional.

Warnings and Precautions

For rectal use only. This product is contraindicated in patients experiencing rectal irritation, abdominal pain, nausea, fever, or vomiting unless directed by a healthcare professional.

Healthcare providers should advise patients to discontinue use and seek medical attention if they experience any of the following symptoms: rectal discomfort, burning sensation, rectal bleeding, or if there is no bowel movement within one hour of administration.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware that it is intended for rectal use only. It is important to discontinue use and consult a healthcare professional if any of the following adverse reactions occur: rectal discomfort, burning sensation, rectal bleeding, or if there is no bowel movement within 1 hour of administration.

Additionally, patients are advised to seek medical advice before using any laxative if they experience a sudden change in bowel habits lasting more than 2 weeks or if they have already used a laxative for more than 1 week. These precautions are essential to ensure safe and effective use of the product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Topwin Speedy Enema (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Topwin Speedy Enema.
Details

Pediatric Use

Pediatric patients aged 3 to 6 years may be administered 10 ml (1.5 g) of Glycerin, or as directed by a healthcare professional. For patients aged 6 years and older, the recommended dosage is 20 ml (3 g) of Glycerin, also as directed by a healthcare professional.

When administering the enema, it is advised that the patient be positioned in a knee-chest or upright position. Prior to insertion, the anus should be lubricated with petroleum jelly. The tip of the enema applicator should be gently inserted into the rectum using a single side-to-side movement to minimize the risk of rectal wall damage. A bowel movement is expected to occur within 15 minutes to 1 hour after administration. Each unit should be discarded after use, and any remaining fluid should not be reused.

It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of glycerin enema during pregnancy. There are no contraindications or risks associated with its use in pregnant patients mentioned in the insert. Additionally, no dosage modifications are specified for individuals who are pregnant. Furthermore, the insert does not outline any special precautions that should be taken when administering this product to pregnant patients. As such, healthcare professionals should consider the absence of specific information while making treatment decisions for pregnant individuals.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and caution is advised when administering to nursing mothers due to the potential risk to the infant.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and adhere to standard protocols for managing potential overdose situations.

In the event of suspected overdosage, it is recommended that healthcare providers monitor the patient closely for any unusual symptoms or adverse reactions. Supportive care should be initiated as necessary, and symptomatic treatment should be provided based on the clinical presentation.

Healthcare professionals are encouraged to report any cases of suspected overdosage to the appropriate regulatory authorities to contribute to the ongoing assessment of the medication's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should not be used in the presence of rectal irritation, abdominal pain, nausea, fever, or vomiting unless specifically directed by a physician.

Patients should be instructed to discontinue use and consult a doctor if they experience any of the following symptoms: rectal discomfort, a burning sensation, rectal bleeding, or if there is no bowel movement within one hour of using the product.

Additionally, healthcare providers should recommend that patients consult a doctor before using any laxative if they have experienced a sudden change in bowel habits lasting more than two weeks or if they have already been using a laxative for more than one week.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product in a cool, dry place, maintaining a temperature below 77°F (25°C) to ensure its integrity. Additionally, the product must be protected from direct sunlight to prevent degradation.

Healthcare professionals should also be aware that the product should not be used if the cap is broken, as this may compromise its safety and efficacy. Proper handling and storage conditions are crucial for maintaining the quality of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Topwin Speedy Enema, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Topwin Speedy Enema, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.